Literature DB >> 24869464

Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings.

Gabor Kovacs1, Alexander Avian, Michael Pienn, Robert Naeije, Horst Olschewski.   

Abstract

The accuracy of pulmonary vascular pressure measurements is of great diagnostic and prognostic relevance. However, there is variability of zero leveling procedures, and the current recommendation of end-expiratory reading may not always be adequate. A review of physiological and anatomical data, supported by recent imaging, leads to the practical recommendation of zero leveling at the cross-section of three transthoracic planes, which are, respectively midchest frontal, transverse through the fourth intercostal space, and midsagittal. As for the inevitable respiratory pressure swings, end-expiratory reading at functional residual capacity allows for minimal influence of elastic lung recoil on pulmonary pressure reading. However, hyperventilation is associated with changes in end-expiratory lung volume and increased intrathoracic pressure, eventually exacerbated by expiratory muscle contraction and dynamic hyperinflation, all increasing pulmonary vascular pressures. This problem is amplified in patients with obstructed airways. With the exception of dynamic hyperinflation states, it is reasonable to assume that negative inspiratory and positive expiratory intrathoracic pressures cancel each other out, so averaging pulmonary vascular pressures over several respiratory cycles is most often preferable. This recommendation may be generalized for the purpose of consistency and makes sense, as pulmonary blood flow measurements are not corrected for phasic inspiratory and expiratory changes in clinical practice.

Entities:  

Keywords:  dynamic hyperinflation; pulmonary artery pressure; pulmonary hypertension; right heart catheterization; zero reference level

Mesh:

Year:  2014        PMID: 24869464     DOI: 10.1164/rccm.201402-0269PP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  33 in total

Review 1.  Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice.

Authors:  Natalia C Berry; Agarwal Manyoo; William M Oldham; Thomas E Stephens; Ronald H Goldstein; Aaron B Waxman; Julie A Tracy; Peter J Leary; Jane A Leopold; Scott Kinlay; Alexander R Opotowsky; David M Systrom; Bradley A Maron
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

2.  The relationship of pulmonary vascular resistance and compliance to pulmonary artery wedge pressure during submaximal exercise in healthy older adults.

Authors:  Stephen P Wright; John T Granton; Sam Esfandiari; Jack M Goodman; Susanna Mak
Journal:  J Physiol       Date:  2016-03-24       Impact factor: 5.182

Review 3.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

Review 4.  The role of hypothalamic-pituitary-gonadal hormones in the normal structure and functioning of the brain.

Authors:  S Vadakkadath Meethal; C S Atwood
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 5.  Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.

Authors:  Sriram D Rao; Jonathan N Menachem; Edo Y Birati; Jeremy A Mazurek
Journal:  Curr Heart Fail Rep       Date:  2019-10

6.  [ESC guidelines 2015 on pulmonary hypertension].

Authors:  H Olschewski; G Kovacs
Journal:  Herz       Date:  2015-12       Impact factor: 1.443

Review 7.  The Evolving Landscape of Exercise-Induced Pulmonary Hypertension.

Authors:  J Sawalla Guseh
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-06

8.  Physical activity in incident patients with pulmonary arterial and chronic thromboembolic hypertension.

Authors:  Stéphanie Saxer; Mona Lichtblau; Charlotte Berlier; Elisabeth D Hasler; Esther I Schwarz; Silvia Ulrich
Journal:  Lung       Date:  2019-07-01       Impact factor: 2.584

Review 9.  World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.

Authors:  Kurt W Prins; Thenappan Thenappan
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

Review 10.  CardioMEMS: where we are and where can we go?

Authors:  Issa Pour-Ghaz; David Hana; Joel Raja; Uzoma N Ibebuogu; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2019-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.